• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; BLOOD GLUCOSE TEST STRIPS Back to Search Results
Model Number 7313
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/20/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Event or Problem Description
The customer reported that she performed a blood glucose testing with the contour next meter at 12:34 p.M.And obtained a reading of 20 mg/dl.The meter automatically marked it as a control test, and so the reading will be displayed as a control result when accessing the meter's memory.There was no allegation of an adverse event.The customer was advised to return the device for evaluation.A replacement meter kit was sent to the customer.
 
Additional Manufacturer Narrative
The customer returned the suspected contour next meter and contour next test strips from lot # 3khec51a for evaluation.The returned meter was tested with the returned test strips using a blood sample, which gave a satisfactory performance.The blood results obtained with the in-house testing were properly marked as blood tests in the meter's memory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
BLOOD GLUCOSE TEST STRIPS
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
PHC CORPORATION (REGISTRATION NUMBER: 1000134386)
2131-1 minamigata
toon ehime, 791-0 395
JA   791-0395
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key20226670
Report Number1810909-2024-00148
Device Sequence Number14320025
Product Code NBW
UDI-Device Identifier10301937313100
UDI-Public10301937313100
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K121190
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial,Followup
Report Date (Section B) 08/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date10/31/2025
Device Model Number7313
Device Lot Number3KHEC51A
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/22/2024
Supplement Date Received by Manufacturer10/30/2024
Initial Report FDA Received Date09/16/2024
Supplement Report FDA Received Date11/04/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age67 YR
Patient SexFemale
-
-